[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[2]
|
World Health Organization (2020) Global Cancer Observatory (GCO): Cancer Today.
http://gco.Iarc.fr/today/home
|
[3]
|
Chen, W., Zheng, R., Baade, P.D., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
|
[4]
|
Ward, E.M., DeSantis, C.E., Lin, C.C., et al. (2015) Cancer Statistics: Breast Cancer in Situ. CA: A Cancer Journal for Clinicians, 65, 481-495. https://doi.org/10.3322/caac.21321
|
[5]
|
陈万青, 郑荣寿. 中国女性乳腺癌发病死亡和生存状况[J]. 中国肿瘤临床, 2015, 42(13): 668-674.
|
[6]
|
Morrow, M., Schnitt, S. and Norton, L. (2015) Current Management of Lesions Associated with an Increased Risk of Breast Cancer. Nature Reviews Clinical Oncology, 12, 227-238. https://doi.org/10.1038/nrclinonc.2015.8
|
[7]
|
Maller, O., Martinson, H. and Schedin, P. (2010) Extracellular Matrix Composition Reveals Complex and Dynamic Stromal-Epithelial Interactions in the Mammary Gland. Journal of Mammary Gland Biology and Neoplasia, 15, 301-318. https://doi.org/10.1007/s10911-010-9189-6
|
[8]
|
Noël, A., Gilles, C. and Foidan, J.-M. (2011) Invasion and Metalstatic Dissemination in Breast Cancer: Mechanisms. Revue Médicale de Liège, 66, 274-278.
|
[9]
|
Maxime, D., Jadwiga, M.W., Ahmed, Z., et al. (2012) Gene Inactivation of Proprotein Convertase Subtil-isin/Kexin Type 9 Reduces Atherosclerosis in Mice. Circulation, 125, 894-901.
https://doi.org/10.1161/CIRCULATIONAHA.111.057406
|
[10]
|
Liu, X., Bao, X., Hu, M., et al. (2020) Inhibition of PCSK9 Potentiates Immune Checkpoint Therapy for Cancer. Nature, 588, 693-698. https://doi.org/10.1038/s41586-020-2911-7
|
[11]
|
Beyaert, R., Beaugerie, L., Van Assche, G., et al. (2013) Cancer Risk in Immune-Mediated Inflammatory Diseases(IMID). Molecular Cancer, 12, Article No. 98. https://doi.org/10.1186/1476-4598-12-98
|
[12]
|
Iuima, J., Konno, K. and Itano, N. (2011) Inflammatory Alterations of the Extracellular Matrix in the Tumor Microenvironment. Cancers, 3, 3189-3205. https://doi.org/10.3390/cancers3033189
|
[13]
|
Tarin, D. (2012) Clinical and Biological Implications of the Tumor Microen-vironment. Cancer Microenvironment, 5, 95-112. https://doi.org/10.1007/s12307-012-0099-6
|
[14]
|
Zhou, N., Zhang, Y., Zhang, X., et al. (2015) Exposure of Tumor-Associated Macrophages to Apoptotic MCF-7 Cells Promotes Breast Cancer Growth and Metastasis. International Journal of Molecular Sciences, 16, 11966-11982.
https://doi.org/10.3390/ijms160611966
|
[15]
|
Lan, H., Pang, L., Smith, M.M., et al. (2010) Proprotein Convertase Subtil-isin/Kexin Type 9 (PCSK9) Affects Gene Expression Pathways beyond Cholesterol Metabolism in Liver Cells. Journal of Cel-lular Physiology, 224, 273-281.
https://doi.org/10.1002/jcp.22130
|
[16]
|
Hampton, E.N., Knuth, M.W., Li, J., et al. (2007) The Self-Inhibited Structure of Full-Length PCSK9 at 1.9 Å Reveals Structural Homology with Resistin within the C-Terminal Domain. Proceedings of the Na-tional Academy of Sciences of the United States of America, 104, 14604-14609. https://doi.org/10.1073/pnas.0703402104
|
[17]
|
刘录山, 谢闵, 姜志胜, 等. PCSK9siRNA对oxLDL诱导的THP-1源性巨噬细胞凋亡的影响[J]. 生物化学与生物物理进展, 2009, 36(3): 323-330.
|
[18]
|
唐志晗, 任重, 武春艳, 等. PCSK9-siRNA在抗ox-LDL诱导的THP-1源性巨噬细胞凋亡中对Bax、Bcl-2表达的影响[J]. 中国动脉硬化杂志, 2011, 19(1): 29-33.
|
[19]
|
Melvin, J.C., Holmberg, L., Rohmann, S., et al. (2013) Serum Lipid Profiles and Cancer Risk in the Con-text of Obesity: Four Meta-Analyses. Journal of Cancer Epidemiology, 2013, Article ID: 823849. https://doi.org/10.1155/2013/823849
|
[20]
|
Irwin, M.E., Mueller, K.L., Bohin, N., Ge, Y. and Boerner, J.L. (2011) Lipid Raft Localization of EGFR Alters the Response of Cancer Cells to the EGFR Tyrosine Kinase Inhibitor Gefitinib. Journal of Cellular Physiology, 226, 2361-2328. https://doi.org/10.1002/jcp.22570
|
[21]
|
Rashid, S., Tavori, H., Brown, P.E., et al. (2014) Proprotein Convertase Subtilisin Kexin Type 9 Promotes Intestinal Overproduction of Triglyceride-Rich Apolipoprotein B Lipoproteins Through Both Low-Density Lipoprotein Receptor-Dependent and -Independent Mechanisms. Circulation, 130, 431-441.
https://doi.org/10.1161/CIRCULATIONAHA.113.006720
|
[22]
|
李正良, 蔡瑜, 张顺财. PCSK9对急性胰腺炎局部并发症及不良预后事件的预测价值[J]. 中国临床医学, 2019, 26(3): 413-419.
|
[23]
|
Rajala, M.W. and Scherer, P.E. (2003) Minireview: The Adipocyte—At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis. Endocrinology, 144, 3765- 3773. https://doi.org/10.1210/en.2003-0580
|
[24]
|
Dirat, B., Bochet, L., Dabek, M., et al. (2011) Can-cer-Associated Adipocytes Exhibit an Activated Phenotype and Contribute to Breast Cancer Invasion. Cancer Research, 71, 2455-2465.
https://doi.org/10.1158/0008-5472.CAN-10-3323
|
[25]
|
李学勤, 徐克. 肿瘤相关成纤维细胞促进肿瘤侵袭转移的作用机制[J]. 中国生物化学与分子生物学报, 2019, 35(4): 386-392.
|
[26]
|
李营歌, 姚颐, 宋启斌, 等. 肿瘤免疫治疗不容忽视的微环境: 癌相关成纤维细胞[J]. 肿瘤学杂志, 2018, 24(11): 1060-1064.
|
[27]
|
Tyan, S.W., Kuo, W.H., Huang, C.K., et al. (2011) Breast Cancer Cells Induce Cancer-Associated Fibroblasts to Secrete Hepato-Cyte Growth Factor to Enhance Breast Tumorigenesis. PLOS ONE, 6, e15313.
https://doi.org/10.1371/journal.pone.0015313
|
[28]
|
Suh, J., Kim, D.-H., Lee, Y.-H., Jang, J.-H. and Surh, Y.-J. (2020) Fi-broblast Growth Factor-2, Derived from Cancer-Associated Fibroblasts, Stimulates Growth and Progression of Human Breast Cancer Cells via FGFR1 Signaling. Molecular Carcinogenesis, 59, 1028-1040. https://doi.org/10.1371/journal.pone.0015313
|
[29]
|
靳天慧, 陈亮, 刘叶红, 等. 敲低前蛋白转化酶枯草溶菌素9 (PCSK9)抑制人主动脉内皮细胞的内皮间质转化[J]. 细胞与分子免疫学杂志, 2021, 37(12): 1079-1084.
|